Ono Phar­ma­ceu­ti­cal ac­quires De­ci­phera for $2.4B af­ter biotech's Phase 3 win

Japan­ese drug­mak­er Ono Phar­ma­ceu­ti­cal is ac­quir­ing can­cer-fo­cused biotech De­ci­phera Phar­ma­ceu­ti­cals for $2.4 bil­lion, the com­pa­nies an­nounced Mon­day morn­ing.

The deal will see Ono ac­quire all …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER